These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 12699596
1. A stepwise approach to the treatment of amiodarone-induced thyrotoxicosis. Erdogan MF, Güleç S, Tutar E, Başkal N, Erdogan G. Thyroid; 2003 Feb; 13(2):205-9. PubMed ID: 12699596 [Abstract] [Full Text] [Related]
2. Amiodarone-induced thyrotoxicosis. A review. Piga M, Serra A, Boi F, Tanda ML, Martino E, Mariotti S. Minerva Endocrinol; 2008 Sep; 33(3):213-28. PubMed ID: 18846027 [Abstract] [Full Text] [Related]
3. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis. Bogazzi F, Bartalena L, Brogioni S, Mazzeo S, Vitti P, Burelli A, Bartolozzi C, Martino E. Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940 [Abstract] [Full Text] [Related]
10. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. J Clin Endocrinol Metab; 1996 Aug; 81(8):2930-3. PubMed ID: 8768854 [Abstract] [Full Text] [Related]
11. Glucocorticoids are preferable to thionamides as first-line treatment for amiodarone-induced thyrotoxicosis due to destructive thyroiditis: a matched retrospective cohort study. Bogazzi F, Tomisti L, Rossi G, Dell'Unto E, Pepe P, Bartalena L, Martino E. J Clin Endocrinol Metab; 2009 Oct; 94(10):3757-62. PubMed ID: 19622616 [Abstract] [Full Text] [Related]
12. Clinical characteristics of amiodarone-induced thyrotoxicosis and hypothyroidism in Japan. Sato K, Miyakawa M, Eto M, Inaba T, Matsuda N, Shiga T, Ohnishi S, Kasanuki H. Endocr J; 1999 Jun; 46(3):443-51. PubMed ID: 10503998 [Abstract] [Full Text] [Related]
13. Treatment of amiodarone-induced thyrotoxicosis type 2: a randomized clinical trial. Eskes SA, Endert E, Fliers E, Geskus RB, Dullaart RP, Links TP, Wiersinga WM. J Clin Endocrinol Metab; 2012 Feb; 97(2):499-506. PubMed ID: 22130792 [Abstract] [Full Text] [Related]
16. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clin Endocrinol (Oxf); 2002 Jan; 56(1):33-8. PubMed ID: 11849244 [Abstract] [Full Text] [Related]
17. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. Martino E, Aghini-Lombardi F, Mariotti S, Lenziardi M, Baschieri L, Braverman LE, Pinchera A. J Endocrinol Invest; 1986 Jun; 9(3):201-7. PubMed ID: 3020113 [Abstract] [Full Text] [Related]
18. An audit of amiodarone-induced thyrotoxicosis--do anti-thyroid drugs alone provide adequate treatment? Patel N, Inder WJ, Sullivan C, Kaye G. Heart Lung Circ; 2014 Jun; 23(6):549-54. PubMed ID: 24613043 [Abstract] [Full Text] [Related]
19. Diagnosis and management of amiodarone-induced thyrotoxicosis in Europe: results of an international survey among members of the European Thyroid Association. Bartalena L, Wiersinga WM, Tanda ML, Bogazzi F, Piantanida E, Lai A, Martino E. Clin Endocrinol (Oxf); 2004 Oct; 61(4):494-502. PubMed ID: 15473883 [Abstract] [Full Text] [Related]